Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02734238 · ClinicalTrials.gov registry record · Phase 4
Physiological and Psychological Effects of Testosterone During Severe Energy Deficit and Recovery
A Phase 4 study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 53
- Enrollment target
NCT02734238 is a Phase 4 study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 53 participants.
The verdict
NCT02734238, a Phase 4 study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 53 participants
- Enrollment target
Study Summary
The objective of this study is to determine whether maintaining a eugonadal state, during severe, sustained energy deficit, attenuates physiological decrements, particularly the loss of lean body mass.
Interventions
- DRUG Sesame Oil
- DRUG testosterone enanthate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02734238
The ClinicalTrials.gov registry entry for NCT02734238 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sesame Oil is the first listed.
NCT02734238 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02734238 about?
NCT02734238 is a clinical study titled "Physiological and Psychological Effects of Testosterone During Severe Energy Deficit and Recovery". The objective of this study is to determine whether maintaining a eugonadal state, during severe, sustained energy deficit, attenuates physiological decrements, particularly the loss of lean body mass.
What is the current status of trial NCT02734238?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 53 participants. The study started on 2016-04. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02734238?
The interventions under investigation include: Sesame Oil (DRUG), testosterone enanthate (DRUG).
Who is sponsoring clinical trial NCT02734238?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.